Erasca Inc (ERAS)
Healthcare
Biotechnology
18.20 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Erasca Inc (ERAS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -27 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -24 | -25 | -33 | -29 | -22 | -25 | -32 | -21 | -22 | -22 | -27 | -91 | |
| 1.0 | 0.9 | 0.9 | 1.0 | 1.1 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 3.0 | |
| 7.0 | 6.2 | 6.1 | 6.8 | 7.2 | 6.6 | 6.3 | 6.7 | 6.4 | 6.0 | 5.8 | 8.5 | 27 | |
| 7.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.7 | 1.4 | 0.0 | -3.7 | 0.5 | 3.8 | 1.1 | -6.1 | 0.2 | 1.3 | 1.4 | -2.3 | 0.5 | |
| 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -109 | -1.8 | 4.5 | 10.0 | -87 | -103 | 23 | 34 | 16 | 26 | 25 | -244 | -178 | |
| 0.1 | – | 0.8 | – | – | 0.4 | 0.4 | – | 0.4 | – | 0.3 | – | – | |
| 0.6 | 0.0 | 0.5 | 6.9 | 212 | 21 | 0.8 | 0.0 | 0.4 | 0.0 | 0.6 | 245 | 246 | |
| -134 | -26 | -20 | -16 | 96 | -104 | -1.1 | 2.7 | -4.3 | 4.1 | 3.6 | -27 | -23 | |
| -26 | -24 | -25 | -33 | -29 | -22 | -25 | -32 | -21 | -22 | -22 | -27 | -91 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.